Latest Health News

333D Limited has had its trading suspension lifted following a capital raise announcement and response to an ASX price query, signaling renewed market activity.

EV Resources has made significant strides at its Los Lirios Antimony Project in Mexico, completing key infrastructure and identifying multiple high-grade drill targets as it moves closer to resource definition.

Nyrada Inc. has released compelling preclinical data showing its drug candidate Xolatryp protects mitochondrial function by reducing calcium overload in brain injury models, bolstering confidence ahead of its Phase IIa trial in acute myocardial infarction.

TMK Energy Limited’s trading suspension on the ASX has been lifted as the company lodges its Half Yearly Report, reopening its shares to market activity from 16 September 2025.

Brightstar Resources reports underground mining operations at its Laverton Hub are significantly ahead of schedule, targeting a +50% quarter-on-quarter production increase in the September quarter. The Fish Mine has turned cash flow positive, underpinning a robust growth outlook.

Tesoro Gold has released an expanded and upgraded scoping study for its Ternera open pit project in Chile, revealing strong economics and a 1.82 million ounce gold resource. The study highlights a straightforward development path with low capital costs and excellent gold recoveries.

First Graphene’s UK partner Vector Group has filed patents for novel fire-resistant materials enhanced with PureGRAPH graphene, showing 100% self-extinguishing performance and improved safety for construction.

Xstate Resources Limited has had its trading suspension lifted as it meets key ASX listing requirements, marking a new chapter for the mining company.

Thrive Tribe Technologies has raised approximately $500,000 through a discounted share placement, aiming to bolster its working capital. The move follows shareholder approval and involves a significant issuance of new shares.

Downer EDI Limited has announced its key shareholder dates for 2025, including the Annual General Meeting scheduled for November 11 and the final dividend payment on October 2. These dates mark important milestones for investors in one of Australia and New Zealand's leading infrastructure service providers.

Adherium Limited’s iCARE study reports unprecedented medication adherence improvements and sustained patient engagement in COPD and asthma care, highlighting significant clinical and economic benefits.

TMK Energy Limited’s securities have been suspended from ASX trading due to a missed periodic report deadline, raising questions about the company’s regulatory adherence and market outlook.